首页> 外文OA文献 >Value of fine-needle aspiration cytology in diagnosis of Hodgkin's lymphoma and anaplastic large cell lymphoma: one centre experience
【2h】

Value of fine-needle aspiration cytology in diagnosis of Hodgkin's lymphoma and anaplastic large cell lymphoma: one centre experience

机译:细针穿刺细胞学检查对霍奇金淋巴瘤和间变性大细胞淋巴瘤的诊断价值:一中心体会

摘要

The aim of the study was to determine the value and limitations of cytology in diagnosis of Hodgkin’s lymphoma (HL) and anaplastic large cell lymphoma (ALCL) as well as differentiation between these two entities. We analysed the FNA cytodiagnoses and histopathological reports, as well as treatment and survival in 89 newly diagnosed consecutive patients with these lymphomas treated in our clinical department. These patients (40 male, 49 female; age range 16–93 years; 44 in clinical stages I–II; 38 with B symptoms) were diagnosed and treated during a period of 64 months (1.1. 2004–1.5.2009). The FNA cytodiagnoses were available in 86 patients and the pathohistological diagnoses were available in 84 patients. Cytology revealed 65 classic HL, 18 ALCL and three patients in which diagnosis was not informative. Among 65 FNA cytodiagnoses of HL, comparison with histopathology was made in 61 cases and the histopathological diagnoses were as follows: 56 (91.8%) HL; three ALCL; one diffuse large B cell lymphoma and one marginal zone B cell lymphoma. In the group of 18 FNA cytodiagnoses of ALCL eight patients (53.3%) had definitive diagnosis of ALCL (either as T-cell or O type), five (33.3%) of HL and in three cases a histopathological diagnosis could not be made. These results confirm the value of FNA in diagnostic procedure in patients with HL and ALCL, especially in HL group of patients. Since we have an almost uniform group of patients according to therapeutic approach, we did univariate analyses and found out that patients with FNA cytodiagnoses of HL, younger than 55 years, with early stage of the disease and without B symptoms had significantly longer overall survival (OS). FNA cytodiagnosis has clinical relevance in differentiation between HL and ALCL.
机译:这项研究的目的是确定细胞学在诊断霍奇金淋巴瘤(HL)和间变性大细胞淋巴瘤(ALCL)以及区分这两种实体中的价值和局限性。我们分析了FNA的细胞诊断和组织病理学报告,以及在我们临床科室治疗的89例新诊断的这些淋巴瘤连续患者的治疗和生存率。这些患者(男40例,女49例;年龄16-93岁; I-II期44例; B症状38例)在64个月内(1.1.2004-1.5.2009)得到诊断和治疗。 FNA细胞诊断可用于86例患者,病理组织学诊断可用于84例患者。细胞学检查发现65例经典HL,18例ALCL和3例诊断不明确的患者。在65例FNA HL的细胞学诊断中,有61例与组织病理学进行了比较,其组织病理学诊断如下:56例(91.8%)HL;三个ALCL; 1例弥漫性大B细胞淋巴瘤和1例边缘区B细胞淋巴瘤。在18例FCL的ALCL细胞诊断中,有8例(53.3%)明确诊断为ALCL(T细胞或O型),5例(33.3%)HL,在3例中无法进行组织病理学诊断。这些结果证实了FNA在HL和ALCL患者尤其是HL组患者的诊断程序中的价值。由于根据治疗方法我们有几乎统一的患者组,因此我们进行了单因素分析,发现患有FNA的HL细胞诊断为HL,年龄小于55岁,疾病早期且无B症状的患者的总生存期明显更长(操作系统)。 FNA细胞诊断与HL和ALCL的鉴别具有临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号